PAI
Palo Alto Investors’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $25.8M | Buy |
205,759
+836
| +0.4% | +$105K | 5.5% | 6 |
|
|
2025
Q1 | $28M | Buy |
204,923
+14,775
| +8% | +$2.02M | 5.34% | 6 |
|
|
2024
Q4 | $29.1M | Sell |
190,148
-38,768
| -17% | -$5.93M | 4.51% | 7 |
|
|
2024
Q3 | $44.4M | Sell |
228,916
-60,134
| -21% | -$11.7M | 5.76% | 5 |
|
|
2024
Q2 | $67M | Sell |
289,050
-908
| -0.3% | -$210K | 7.76% | 5 |
|
|
2024
Q1 | $62.5M | Sell |
289,958
-90,459
| -24% | -$19.5M | 7.05% | 4 |
|
|
2023
Q4 | $98.4M | Sell |
380,417
-865
| -0.2% | -$224K | 8.87% | 4 |
|
|
2023
Q3 | $98M | Hold |
381,282
| – | – | 9.27% | 5 |
|
|
2023
Q2 | $109M | Hold |
381,282
| – | – | 8.77% | 7 |
|
|
2023
Q1 | $106M | Buy |
381,282
+1,200
| +0.3% | +$334K | 8.78% | 5 |
|
|
2022
Q4 | $105M | Buy |
380,082
+19,101
| +5% | +$5.29M | 8.97% | 5 |
|
|
2022
Q3 | $96.4M | Hold |
360,981
| – | – | 7.62% | 8 |
|
|
2022
Q2 | $73.6M | Hold |
360,981
| – | – | 6.42% | 7 |
|
|
2022
Q1 | $76M | Sell |
360,981
-24,019
| -6% | -$5.06M | 5.88% | 8 |
|
|
2021
Q4 | $92.4M | Buy |
385,000
+23,400
| +6% | +$5.61M | 5.9% | 7 |
|
|
2021
Q3 | $102M | Hold |
361,600
| – | – | 6.18% | 7 |
|
|
2021
Q2 | $125M | Buy |
361,600
+18,400
| +5% | +$6.37M | 6.9% | 5 |
|
|
2021
Q1 | $96M | Buy |
343,200
+108,900
| +46% | +$30.5M | 5.47% | 7 |
|
|
2020
Q4 | $57.4M | Buy |
+234,300
| New | +$57.4M | 3.01% | 12 |
|